Status:

COMPLETED

PET Scan and CT Scan in Evaluating Response in Patients Undergoing Radiofrequency Ablation for Lung Metastases

Lead Sponsor:

Institut Bergonié

Conditions:

Metastatic Cancer

Unspecified Adult Solid Tumor, Protocol Specific

Eligibility:

All Genders

18-120 years

Phase:

NA

Brief Summary

RATIONALE: Radiofrequency ablation uses a high-frequency, electric current to kill tumor cells. Diagnostic procedures, such as PET scan and CT scan, may help doctors measure the patient's response to ...

Detailed Description

OBJECTIVES: Primary * Determine the accuracy of positron emission tomography (PET) and CT scan in measuring response at 3 months after radiofrequency ablation (RFA) in patients with lung metastases....

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Histologically confirmed cancer
  • Radiologically suspected pulmonary metastases
  • May be confirmed histologically or by specific markers
  • Less than 6 lesions
  • Lesions \< 40 mm
  • Prior positron emission tomography shows 1 hyperfixation (standard uptake variable \> 3) at the level of lesions to be treated
  • Lesions must not be attached to or next to major mediastinal structures
  • Radiofrequency ablation planned as treatment
  • PATIENT CHARACTERISTICS:
  • Life expectancy \> 6 months
  • No uncontrolled medical condition, including any of the following:
  • Psychiatric condition
  • Infection
  • Coronary insufficiency
  • New York Heart Association class III-IV heart disease
  • No other serious condition
  • No contraindication to general anesthesia
  • Not pregnant or nursing
  • PRIOR CONCURRENT THERAPY:
  • At least 30 days since prior participation in an investigational study
  • At least 30 days since prior chemotherapy
  • No other concurrent investigational agents

Exclusion

    Key Trial Info

    Start Date :

    May 2 2005

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    May 1 2011

    Estimated Enrollment :

    89 Patients enrolled

    Trial Details

    Trial ID

    NCT00382252

    Start Date

    May 2 2005

    End Date

    May 1 2011

    Last Update

    March 9 2022

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Centre Hospitalier de la Cote Basque

    Bayonne, France, 64100

    2

    Institut Bergonie

    Bordeaux, France, 33076

    3

    Hopital Haut Leveque

    Pessac, France, 33604